The ACR advocates on behalf of the rheumatology community throughout the year, but it’s always especially exciting when patients join our efforts in Washington, D.C. Close to 100 patients, rheumatologists and representatives of the broader interprofessional team traveled to our nation’s capital this week to participate in the ACR’s annual Advocates for Arthritis event. Participants…
Out of Africa: Pattern, Genetics & Advocacy of Rheumatic Diseases
Rheumatic diseases were once thought of as rare on the African continent. But one session during the 2018 ACR/ARHP Annual Meeting, will dispel this perception—with three speakers presenting on the state of rheumatic disease in Africa…
Celiac Awareness Makes a Difference for Rheumatology Patients
Celiac disease and gluten sensitivity are difficult to diagnose, but they affect multiple systems and are associated with other autoimmune diseases. Lan Chen, MD, PhD, believes better testing and clearer education will be a gamechanger for celiac patients…
California Insurance Commissioner Sues AbbVie over Humira
(Reuters)—On Tuesday, Insurance Commissioner Dave Jones filed a complaint on behalf of the State of California against AbbVie Inc., alleging the drugmaker gave illegal kickbacks to healthcare providers to prescribe its blockbuster drug, Humira. The regulator alleged that AbbVie engaged in a far-reaching scheme including cash, meals, drinks, gifts, trips and patient referrals, as well…
2018 RISE Users Meeting Guides You through MIPS Submission
During the 2018 ACR/ARHP Annual Meeting, the ACR’s Registry Team will hold a RISE user group meeting to showcase the innovative, new RISE dashboard, designed to help maximize your performance scores for MIPS submission. We welcome current RISE users to share their experiences thus far and to be part of the improvement process as we…
What to See in Chicago during the 2018 ACR/ARHP Annual Meeting
With magnificent skylines and a reputation for art, culture and fun, Chicago is a great setting for the 2018 ACR/ARHP Annual Meeting. Here are some must-see places in our host city…
Piclidenoson in Trials for Psoriasis & RA; Plus Duzallo Approved in Europe
New clinical trials are underway to determine the safety and efficacy of piclidenoson for patients with plaque psoriasis and rheumatoid arthritis…
Sessions to Check Out During the 2018 ACR/ARHP Annual Meeting
With more than 450 sessions, the 2018 ACR/ARHP Annual Meeting, is your gateway to global rheumatology education. Here is a preview of a few sessions attendees can look forward to…
Advocates for Arthritis Fly-In Event Benefits Rheumatology Patients
Pendaar Pooyan was diagnosed with juvenile idiopathic arthritis (JIA) in elementary school. He learned to ask for what he needed: use of a computer in class because of wrist pain and a locker that didn’t require him to bend down so far. And he learned to talk about his disease. This helped make participating for…
Bone Mineral Density Most Important Determinant of Fracture Risk
NEW YORK (Reuters Health)—In what is believed to be the largest study investigating genetic and clinical determinants of osteoporotic fracture risk, only a genetic predisposition to low bone mineral density (BMD) had a potential causal role to play. “Notably, genetic predisposition to lower levels of vitamin D and estimated calcium intake from dairy sources were…
- « Previous Page
- 1
- …
- 138
- 139
- 140
- 141
- 142
- …
- 316
- Next Page »